Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Idorsia
Pharma
Idorsia's Tryvio nabs FDA approval following buyback from J&J
Idorsia's Tryvio is the first oral anti-hypertensive therapy that uses a new therapeutic mechanism in nearly 40 years, the company said.
Zoey Becker
Mar 20, 2024 12:40pm
Viatris still hungry for deals after pact with Idorsia: CEO
Feb 28, 2024 10:45am
Sosei ushers in new era with Nxera Pharma name change
Feb 16, 2024 3:30am
Idorsia's insomnia drug enters clinic as a treatment for PTSD
May 10, 2023 9:00am
Idorsia requests to de-schedule DORA insomnia drugs
Apr 7, 2023 10:55am
Intra-Cellular winner of the Fierce Madness Drug Ad Tournament
Mar 22, 2023 8:30am
